Cargando…
Pharmacokinetics of Non-β-Lactam β-Lactamase Inhibitors
The growing emergence of drug-resistant bacterial strains is an issue to treat severe infections, and many efforts have identified new pharmacological agents. The inhibitors of β-lactamases (BLI) have gained a prominent role in the safeguard of beta-lactams. In the last years, new β-lactam–BLI combi...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8300739/ https://www.ncbi.nlm.nih.gov/pubmed/34202609 http://dx.doi.org/10.3390/antibiotics10070769 |